Changes in cellular glycosylation of leukemia cells upon treatment with acridone derivatives yield insight into drug action

Yini Wang, Dayoung Park, Ace G. Galermo, Dan Gao, Hongxia Liu, Carlito B Lebrilla

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

A new acridone derivative 2-aminoacetamido-10-(3, 5-dimethoxy)-benzyl-9(10H)-acridone hydrochloride (8a) has been shown to have potent antitumor activity. In order to understand the underlying action mechanism of 8a, three compounds of the same class with structures optimized step-by-step, 9(10H)-acridone (A), 10-(3,5-dimethoxy) benzyl-9(10H)-acridone (I) and 8a, were exposed to CCRF-CEM leukemia cell to determine the N-glycosylation changes using the microfluidic HPLC-chip-TOF MS platform. N-Glycans from whole cell lysates (WCL) and cell membranes (CM) were analyzed using isomer-sensitive chip-based porous graphitized carbon nano-LC/MS. A total of 223 N-glycan compositions and 398 N-glycan compounds were identified. Comparison of the two analyses showed that more apparent changes were observed in the CM compared with WCL, suggesting that CM may be a more sensitive indicator of changes in glycosylation. Upon 8a exposure to CCRF-CEM cells, a significant decrease in high-mannose-type glycans was observed. Different expressions of oligosaccharyltransferase subunits appear to play a key functional role in regulating the hypoglycosylation and contribute to the action mechanism of 8a. Taken together our findings suggest that glycosylation is strongly affected by therapeutic potency and can be used as possible biomarkers for monitoring toxicity and antitumor activity of 8a.

Original languageEnglish (US)
Pages (from-to)2977-2988
Number of pages12
JournalProteomics
Volume16
Issue number23
DOIs
StatePublished - Dec 1 2016

Fingerprint

Glycosylation
Polysaccharides
Leukemia
Cell membranes
Derivatives
Cell Membrane
Pharmaceutical Preparations
Microfluidics
Biomarkers
Mannose
Isomers
Toxicity
Carbon
High Pressure Liquid Chromatography
acridone
Monitoring
Chemical analysis

Keywords

  • Acridone derivatives
  • Cell membrane
  • Glycoproteomics
  • N-glycosylation
  • OST
  • Structural isomers

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Changes in cellular glycosylation of leukemia cells upon treatment with acridone derivatives yield insight into drug action. / Wang, Yini; Park, Dayoung; Galermo, Ace G.; Gao, Dan; Liu, Hongxia; Lebrilla, Carlito B.

In: Proteomics, Vol. 16, No. 23, 01.12.2016, p. 2977-2988.

Research output: Contribution to journalArticle

Wang, Yini ; Park, Dayoung ; Galermo, Ace G. ; Gao, Dan ; Liu, Hongxia ; Lebrilla, Carlito B. / Changes in cellular glycosylation of leukemia cells upon treatment with acridone derivatives yield insight into drug action. In: Proteomics. 2016 ; Vol. 16, No. 23. pp. 2977-2988.
@article{f357ea5a1e584cb99576c23a07e56f78,
title = "Changes in cellular glycosylation of leukemia cells upon treatment with acridone derivatives yield insight into drug action",
abstract = "A new acridone derivative 2-aminoacetamido-10-(3, 5-dimethoxy)-benzyl-9(10H)-acridone hydrochloride (8a) has been shown to have potent antitumor activity. In order to understand the underlying action mechanism of 8a, three compounds of the same class with structures optimized step-by-step, 9(10H)-acridone (A), 10-(3,5-dimethoxy) benzyl-9(10H)-acridone (I) and 8a, were exposed to CCRF-CEM leukemia cell to determine the N-glycosylation changes using the microfluidic HPLC-chip-TOF MS platform. N-Glycans from whole cell lysates (WCL) and cell membranes (CM) were analyzed using isomer-sensitive chip-based porous graphitized carbon nano-LC/MS. A total of 223 N-glycan compositions and 398 N-glycan compounds were identified. Comparison of the two analyses showed that more apparent changes were observed in the CM compared with WCL, suggesting that CM may be a more sensitive indicator of changes in glycosylation. Upon 8a exposure to CCRF-CEM cells, a significant decrease in high-mannose-type glycans was observed. Different expressions of oligosaccharyltransferase subunits appear to play a key functional role in regulating the hypoglycosylation and contribute to the action mechanism of 8a. Taken together our findings suggest that glycosylation is strongly affected by therapeutic potency and can be used as possible biomarkers for monitoring toxicity and antitumor activity of 8a.",
keywords = "Acridone derivatives, Cell membrane, Glycoproteomics, N-glycosylation, OST, Structural isomers",
author = "Yini Wang and Dayoung Park and Galermo, {Ace G.} and Dan Gao and Hongxia Liu and Lebrilla, {Carlito B}",
year = "2016",
month = "12",
day = "1",
doi = "10.1002/pmic.201600218",
language = "English (US)",
volume = "16",
pages = "2977--2988",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "23",

}

TY - JOUR

T1 - Changes in cellular glycosylation of leukemia cells upon treatment with acridone derivatives yield insight into drug action

AU - Wang, Yini

AU - Park, Dayoung

AU - Galermo, Ace G.

AU - Gao, Dan

AU - Liu, Hongxia

AU - Lebrilla, Carlito B

PY - 2016/12/1

Y1 - 2016/12/1

N2 - A new acridone derivative 2-aminoacetamido-10-(3, 5-dimethoxy)-benzyl-9(10H)-acridone hydrochloride (8a) has been shown to have potent antitumor activity. In order to understand the underlying action mechanism of 8a, three compounds of the same class with structures optimized step-by-step, 9(10H)-acridone (A), 10-(3,5-dimethoxy) benzyl-9(10H)-acridone (I) and 8a, were exposed to CCRF-CEM leukemia cell to determine the N-glycosylation changes using the microfluidic HPLC-chip-TOF MS platform. N-Glycans from whole cell lysates (WCL) and cell membranes (CM) were analyzed using isomer-sensitive chip-based porous graphitized carbon nano-LC/MS. A total of 223 N-glycan compositions and 398 N-glycan compounds were identified. Comparison of the two analyses showed that more apparent changes were observed in the CM compared with WCL, suggesting that CM may be a more sensitive indicator of changes in glycosylation. Upon 8a exposure to CCRF-CEM cells, a significant decrease in high-mannose-type glycans was observed. Different expressions of oligosaccharyltransferase subunits appear to play a key functional role in regulating the hypoglycosylation and contribute to the action mechanism of 8a. Taken together our findings suggest that glycosylation is strongly affected by therapeutic potency and can be used as possible biomarkers for monitoring toxicity and antitumor activity of 8a.

AB - A new acridone derivative 2-aminoacetamido-10-(3, 5-dimethoxy)-benzyl-9(10H)-acridone hydrochloride (8a) has been shown to have potent antitumor activity. In order to understand the underlying action mechanism of 8a, three compounds of the same class with structures optimized step-by-step, 9(10H)-acridone (A), 10-(3,5-dimethoxy) benzyl-9(10H)-acridone (I) and 8a, were exposed to CCRF-CEM leukemia cell to determine the N-glycosylation changes using the microfluidic HPLC-chip-TOF MS platform. N-Glycans from whole cell lysates (WCL) and cell membranes (CM) were analyzed using isomer-sensitive chip-based porous graphitized carbon nano-LC/MS. A total of 223 N-glycan compositions and 398 N-glycan compounds were identified. Comparison of the two analyses showed that more apparent changes were observed in the CM compared with WCL, suggesting that CM may be a more sensitive indicator of changes in glycosylation. Upon 8a exposure to CCRF-CEM cells, a significant decrease in high-mannose-type glycans was observed. Different expressions of oligosaccharyltransferase subunits appear to play a key functional role in regulating the hypoglycosylation and contribute to the action mechanism of 8a. Taken together our findings suggest that glycosylation is strongly affected by therapeutic potency and can be used as possible biomarkers for monitoring toxicity and antitumor activity of 8a.

KW - Acridone derivatives

KW - Cell membrane

KW - Glycoproteomics

KW - N-glycosylation

KW - OST

KW - Structural isomers

UR - http://www.scopus.com/inward/record.url?scp=85001968761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85001968761&partnerID=8YFLogxK

U2 - 10.1002/pmic.201600218

DO - 10.1002/pmic.201600218

M3 - Article

C2 - 27717196

AN - SCOPUS:85001968761

VL - 16

SP - 2977

EP - 2988

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 23

ER -